For now, it is advisable for individuals taking GLP-1 medications, such as semaglutide or tirzepatide, to discuss any new or unusual symptoms with a healthcare professional.
While liquid sublingual semaglutide presents exciting opportunities, it is important to ensure this medication is prescribed and compounded carefully to suit each patients unique needs
The abdomen typically has more subcutaneous fat and may be less painful for some users
In studies treated with cabergoline, reduction in fasting insulin and HOMA-IR also correlated with cabergoline dose but not to body weight and BMI, suggesting that directly cabergoline could modulate insulin secretion and sensitivity
Diala Alatassi, MD, FACP Medical Reviewer Diala Alatassi, MD, is a board-certified obesity medicine specialist who is committed to providing comprehensive, compassionate, and personalized care